Australia vs Pakistan: Proportion of isolates with decreased susceptibility or resistance
Australia
0.01
in 2020
Pakistan
0
in 2019
Australia rank
12th
Pakistan rank
13th
Proportion of isolates with decreased susceptibility or resistance over time
- Australia
- Pakistan
How they compare
Australia currently reports 0.01 against 0 in Pakistan, a difference of 0.01.
The two have swapped places 2 times across 5 shared years of data; in 2011 it was Australia ahead.
Australia ranks 12th and Pakistan ranks 13th of 52 countries.
Pakistan has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Australia or Pakistan?
- Australia, at 0.01 against 0 in Pakistan as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Australia and Pakistan?
- 0.01, with Australia ahead.
- How many years of comparable data are there for Australia and Pakistan?
- 5 years are reported by both, from 2011 to 2018.
- How do Australia and Pakistan rank globally for proportion of isolates with decreased susceptibility or resistance?
- Australia ranks 12th and Pakistan ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.